Fish collagen peptide

Fish Collagen Peptide Market Dynamics Intelligence, Analysis, and Forecast

I. Market Dynamics Intelligence

1. Market Size and Growth
- China Market Size: In 2025, the Chinese fish collagen peptide market reached RMB 38.6 billion, representing a year-on-year growth of 22.7%. Entering 2026, the market continues its robust expansion momentum, with an expected size of RMB 47.3 billion—a 22.5% increase from 2025—and a two-year compound annual growth rate (CAGR) of 22.6%.
- Global Market Size: In 2025, the global oral collagen peptide market reached USD 18.4 billion, growing at a CAGR of 12.7%, with the Asia-Pacific region contributing over 41% of incremental growth.

2. Key Drivers
- Health-Conscious Consumption Upgrade: Functional foods are gaining heightened awareness and repeat-purchase rates among both Generation Z and senior populations. Fish collagen peptides—distinguished by their high bioavailability, low allergenicity, and clinically validated benefits for skin elasticity improvement and joint support—are establishing differentiated advantages across three core application scenarios: beauty & wellness, sports nutrition, and chronic disease management.
- Policy Support: The National Health Commission has included collagen protein within the regulatory framework for novel food ingredients; meanwhile, the State Administration for Market Regulation has implemented the \"Regulations on Labeling and Claims for Functional Foods,\" permitting scientifically substantiated health claims on product labels—thereby lowering compliance costs for enterprises and enhancing end-consumer education efficiency.
- Supply Chain Localization: Leading domestic enterprises have achieved full-chain technological integration—from targeted deep-sea cod skin sourcing and low-temperature enzymatic hydrolysis to precise nanoscale molecular weight distribution control. Average molecular weight is stably maintained between 800–1,200 Da, with water solubility reaching 99.3%, and dissolution rate improved by 40% versus imported counterparts.

3. Competitive Landscape
- Premium Segment Leaders: The market exhibits a 'one-dominant-player, multiple-strong-players' structure with clearly defined tiered competition, where the premium segment is led by a select group of technologically advanced enterprises.
- Domestic Substitution Progress: The domestic substitution process has evolved comprehensively—from cost-driven replacement to performance-driven and standards-driven replacement. In 2025, domestically produced fish collagen peptides accounted for 63.5% of applications in high-value-added sectors—including premium cosmetic bases and medical nutritional supplements—up 9.2 percentage points from 2024.
- Enhanced Testing Standards: The China National Light Industry Council’s “Group Standard for Fish Collagen Peptide Powder,” implemented in 2025, mandates strict controls across 12 critical parameters—including hydroxyproline content, proportion of tripeptides and longer sequences, and heavy metal residue limits—whose overall rigor exceeds EU regulatory benchmarks.

4. Application Scenario Expansion
- Clinical Healthcare Applications: A Phase II clinical trial on fish collagen peptide intervention for osteoarthritis, led by Peking Union Medical College Hospital, demonstrated that daily intake of 2.5 g for 12 weeks improved WOMAC scores in 61.3% of participants—significantly outperforming the 22.8% improvement observed in the placebo group—providing high-level evidence-based support for prescription-grade nutritional interventions.
- Personalized Customization Demand: In 2025, flexible production line orders enabling customized formulations—tailored by skin type, joint condition, sleep quality, etc., and incorporating co-ingredients such as niacinamide, curcumin, or GABA—accounted for 29.7% of total orders, projected to exceed 38.5% in 2026.

5. Technological Innovation
- Synthetic Biology Pathway: Microconstruct Biotech has successfully developed a non-animal-source fish collagen peptide expression system using a halophilic archaeal chassis; pilot-scale production has achieved a titer of 1.2 g/L. GMP validation is anticipated by 2027—potentially resolving dependency on marine resources and ensuring batch-to-batch consistency.
- Ultra-Micro Molecular Cleavage Technology: Commercialized in 2026, this technology enables production of ultra-short peptides (<500 Da), achieving absorption rates exceeding 92%.

II. Analysis and Judgment

1. Sustained Market Demand Growth
Driven by health-conscious consumption upgrades and supportive policies, demand for fish collagen peptides will continue expanding across beauty & wellness, sports nutrition, and chronic disease management. Notably, expansion into clinical healthcare applications will serve as a new engine of growth.

2. Accelerated Domestic Substitution
Domestic enterprises’ competitive advantages—in technology, standards compliance, and cost efficiency—will become increasingly pronounced. Premium-segment domestic substitution and standards leadership will emerge as focal battlegrounds in future market competition.

3. Technology-Driven Industrial Upgrading
Commercial deployment of frontier technologies—including synthetic biology and ultra-micro molecular cleavage—will propel the fish collagen peptide industry toward higher value, greener practices, and intelligent manufacturing. Technological innovation will become the decisive factor in enterprise competitiveness.

4. Intensifying Market Competition
As market scale expands and domestic substitution accelerates, competition will intensify. Enterprises must continuously elevate product quality, technological capabilities, and brand equity to remain competitive amid mounting pressure.

III. Forecast

1. Market Size Forecast
The Chinese fish collagen peptide market is projected to maintain rapid growth over the coming years. By 2027, market size is expected to surpass RMB 60 billion, sustaining a CAGR above 20%.

2. Application Scenario Expansion Forecast
Advancing technologies and diversifying consumer needs will further broaden application horizons. Beyond existing domains—including beauty & wellness, sports nutrition, and chronic disease management—applications will extend into clinical healthcare, personalized customization, and other emerging fields.

3. Technological Innovation Trend Forecast
Synthetic biology and ultra-micro molecular cleavage technologies will achieve broader adoption across the fish collagen peptide industry. Concurrently, rising consumer expectations regarding product safety and efficacy will drive enterprises to intensify R&D investment and prioritize innovation—enhancing product quality and competitive differentiation.

4. Competitive Landscape Forecast
Future competition will grow more intense yet also more orderly. As industry standards mature and regulatory oversight strengthens, non-compliant players will be phased out. Meanwhile, enterprises possessing technological leadership, strong branding, and superior channel capabilities will emerge as dominant market forces.